Fisher, A. ., Paterson, J. M., Winquist, B. ., Wu, F. ., Reynier, P. ., Suissa, S. ., … Dormuth, C. R. (2022). Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study. PLoS One, 17, e0277623. http://doi.org/10.1371/journal.pone.0277623
S. Suissa
First name
S.
Last name
Suissa
Pradhan, R. ., Lu, S. ., Yin, H. ., H. Y. Yu, O. ., Ernst, P. ., Suissa, S. ., & Azoulay, L. . (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975–1986. http://doi.org/10.2147/copd.s378486
Abenhaim, H. A., Suissa, S. ., Azoulay, L. ., Spence, A. R., Czuzoj-Shulman, N. ., & Tulandi, T. . (2022). Menopausal Hormone Therapy Formulation and Breast Cancer Risk. Obstet Gynecol, 139, 1103–1110. http://doi.org/10.1097/aog.0000000000004723
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109–117. http://doi.org/10.1080/15412555.2022.2035705
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133–141. http://doi.org/10.1080/15412555.2022.2045265
Ozen, G. ., Dell’Aniello, S. ., Pedro, S. ., Michaud, K. ., & Suissa, S. . (2022). Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis. Arthritis Care Res (Hoboken). http://doi.org/10.1002/acr.24866
van Staa, T. P., Cooper, C. ., Leufkens, H. G., Lammers, J. W., & Suissa, S. . (2003). The use of inhaled corticosteroids in the United Kingdom and the Netherlands. Respir Med.
Dial, S. ., Delaney, J. A., Barkun, A. N., & Suissa, S. . (2005). Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. Jama. http://doi.org/10.1001/jama.294.23.2989
Andersohn, F. ., Suissa, S. ., & Garbe, E. . (2006). Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation. http://doi.org/10.1161/circulationaha.105.602425